CoChat

Analysis of DNA variations in promoter region of HCNP gene with Alzheimer’s disease

Okita, Kenji, Matsukawa, Noriyuki, Maki, Mina, Nakazawa, Hideka, Katada, Eiichi, Hattori, Manabu, Akatsu, Hiroyasu, Borlongan, Cesario V., Ojika, Kosei · 2009 · Biochemical and Biophysical Research Communications
Cited by 15

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2008.12.037

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 30

  1. Selkoe, 2008, Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer’s disease, Handb. Clin. Neurol., 89, 245, 10.1016/S0072-9752(07)01223-7 · DOI · Paper page
  2. Takasugi, 2003, The role of presenilin cofactors in the gamma-secretase complex, Nature, 422, 438, 10.1038/nature01506 · DOI · Paper page
  3. Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 · DOI · Paper page
  4. Francis, 1999, The cholinergic hypothesis of Alzheimer’s disease: a review of progress, J. Neurol. Neurosurg. Psychiatry, 66, 137, 10.1136/jnnp.66.2.137 · DOI · Paper page
  5. Coyle, 1983, Alzheimer’s disease: a disorder of cortical cholinergic innervation, Science, 219, 1184, 10.1126/science.6338589 · DOI · Paper page
  6. Whitehouse, 1982, Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain, Science, 215, 1237, 10.1126/science.7058341 · DOI · Paper page
  7. Sugimoto, 2001, Donepezil hydrochloride: a treatment drug for Alzheimer’s disease, Chem. Rec., 1, 63, 10.1002/1528-0691(2001)1:1<63::AID-TCR9>3.0.CO;2-J · doi:10.1002/1528-0691(2001)1:1<63::aid-tcr9>3.0.co;2-j
  8. Sugimoto, 2000, Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors, Curr. Med. Chem., 7, 303, 10.2174/0929867003375191 · DOI · Paper page
  9. Ojika, 2000, Hippocampal cholinergic neurostimulating peptides (HCNP), Prog. Neurobiol., 60, 37, 10.1016/S0301-0082(99)00021-0 · DOI
  10. Matsukawa, 2003, Brain malformations caused by retroviral vector-mediated gene transfer of hippocampal cholinergic neurostimulating peptide precursor protein into the CNS via embryonic mice ventricles, Dev. Neurosci., 25, 349, 10.1159/000073512 · DOI
  11. Yeung, 1999, Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP, Nature, 401, 173, 10.1038/43686 · DOI · Paper page
  12. Belbin, 2007, Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer’s disease, Hum. Mol. Genet., 16, 2199, 10.1093/hmg/ddm171 · DOI · Paper page
  13. Wood, 2007, Association between neprilysin polymorphisms and sporadic Alzheimer’s disease, Neurosci. Lett., 427, 103, 10.1016/j.neulet.2007.09.019 · doi:10.1016/j.neulet.2007.09.019
  14. Tohdoh, 1997, Mechanism of expression of the rat HCNP precursor protein gene, Brain. Res. Mol. Brain Res., 45, 24, 10.1016/S0169-328X(96)00125-8 · doi:10.1016/s0169-328x(96)00125-8
  15. Gardiner-Garden, 1987, CpG islands in vertebrate genomes, J. Mol. Biol., 196, 261, 10.1016/0022-2836(87)90689-9 · DOI · Paper page
  16. Butler, 2002, The RNA polymerase II core promoter: a key component in the regulation of gene expression, Genes Dev., 16, 2583, 10.1101/gad.1026202 · DOI · Paper page
  17. Bird, 1986, CpG-rich islands and the function of DNA methylation, Nature, 321, 209, 10.1038/321209a0 · DOI · Paper page
  18. Iwase, 2001, Muscarinic cholinergic and glutamatergic reciprocal regulation of expression of hippocampal cholinergic neurostimulating peptide precursor protein gene in rat hippocampus, Neuroscience, 102, 341, 10.1016/S0306-4522(00)00495-4 · DOI
  19. Maki, 2002, Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease, J. Neuropathol. Exp. Neurol., 61, 176, 10.1093/jnen/61.2.176 · DOI · Paper page
  20. George, 2006, Decreased phosphatidylethanolamine binding protein expression correlates with Aβ accumulation in the Tg2576 mouse model of Alzheimer’s disease, Neurobiol. Aging, 27, 614, 10.1016/j.neurobiolaging.2005.03.014 · DOI
  21. Chen, 2006, Identification and characterization of PEBP as a calpain substrate, J. Neurochem., 99, 1133, 10.1111/j.1471-4159.2006.04160.x · DOI
  22. Scarpa, 2006, Gene silencing through methylation: an epigenetic intervention on Alzheimer disease, J. Alzheimers Dis., 9, 407, 10.3233/JAD-2006-9406 · DOI · Paper page
  23. Struys, 2000, Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry, Clin. Chem., 46, 1650, 10.1093/clinchem/46.10.1650 · DOI
  24. Morrison, 1996, Brain S-adenosylmethionine levels are severely decreased in Alzheimer’s disease, J. Neurochem., 67, 1328, 10.1046/j.1471-4159.1996.67031328.x · DOI · Paper page
  25. Seshadri, 2002, Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease, N. Engl. J. Med., 346, 476, 10.1056/NEJMoa011613 · DOI · Paper page
  26. Mulder, 2005, The transmethylation cycle in the brain of Alzheimer patients, Neurosci. Lett., 386, 69, 10.1016/j.neulet.2005.03.073 · DOI
  27. Fuso, 2005, S-Adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production, Mol. Cell. Neurosci., 28, 195, 10.1016/j.mcn.2004.09.007 · DOI · Paper page
  28. Castegna, 2003, Proteomic identification of nitrated proteins in Alzheimer’s disease brain, J. Neurochem., 85, 1394, 10.1046/j.1471-4159.2003.01786.x · DOI · Paper page
  29. Butterfield, 2002, Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress, Free Radic. Biol. Med., 32, 1050, 10.1016/S0891-5849(02)00794-3 · DOI · Paper page
  30. Prasad, 1998, Regional membrane phospholipid alterations in Alzheimer’s disease, Neurochem. Res., 23, 81, 10.1023/A:1022457605436 · DOI · Paper page

Cited by

See all 15

Metadata

Authors
Okita, K., Matsukawa, N., Maki, M., Nakazawa, H., Katada, E., Hattori, M., Akatsu, H., Borlongan, C. V., & Ojika, K.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2009-02
Volume
379
Issue
2
Pages
272-276
ISSN
0006-291X
Cited by
15
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of DNA variations in promoter region of HCNP gene with Alzheimer’s disease. https://app.cochat.ai/papers/10.1016/j.bbrc.2008.12.037
The paper
Okita, K., Matsukawa, N., Maki, M., Nakazawa, H., Katada, E., Hattori, M., Akatsu, H., Borlongan, C. V., & Ojika, K. (2009). Analysis of DNA variations in promoter region of HCNP gene with Alzheimer’s disease. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2008.12.037

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.